Drug intelligence / Profile preview

penicillin V + amoxicillin

Development stage
Unknown
Lead developer
Jiangsu Weiqida Pharmaceutical
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Penicillin V and amoxicillin are beta-lactam antibiotics belonging to the penicillin and aminopenicillin classes, respectively. Developed and manufactured by Jiangsu Weiqida Pharmaceutical, these agents are used to treat a wide range of bacterial infections. Both drugs exert their antibacterial effect by binding to and inhibiting penicillin-binding proteins (PBPs), which are essential enzymes involved in the synthesis and remodeling of the bacterial cell wall. Inhibition of PBPs leads to the weakening of the cell wall and subsequent bacterial lysis. While the pipeline context lists these as separate products (including Penicillin V Potassium tablets and Amoxicillin capsules/injectables), they represent the core of the company's penicillin-based anti-infective portfolio.

Brand names
阿克威奇达阿克干混盒阿莫西林胶囊阿莫西林颗粒青霉素V钾片威奇达-青霉素V钾颗粒注射用阿莫西林钠
Other names
penicillin V potassiumphenoxymethylpenicillinamoxicillin sodiumpenicillin Vamoxicillin
02

Targets

PBP1b (Penicillin-binding protein 1B)PBP1A (Penicillin-binding protein 1A)PBP2x (Penicillin-binding protein 2x)

Beyond the preview

Go deeper on penicillin V + amoxicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on penicillin V + amoxicillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call